PSG’s Post

The short answer is: No it isn't... It is not a Trade show nor a conference.. The Medical Device Manufacturing and R&D Summit is your gateway to this future. An exclusive enclave where the best minds in medical device manufacturing and R&D converge with the avant-garde of suppliers and solution innovators. 📢 Why this summit is unmissable: ✅Elite Networking: Picture yourself exchanging insights with the crème de la crème of the industry. This is where deals are made, and futures are forged. ✅Frontline Innovations: Get hands-on with the next-gen technologies redefining what's possible in healthcare. Your next breakthrough starts here. ✅Masterclass Insights: Absorb wisdom from the pioneers who've blazed trails. Visionary keynotes, real-world case studies, and interactive forums designed to empower and inspire. ✅Collaboration in Action: Discover partners who can translate your bold ideas into breathtaking realities. It's more than a summit; it's a launchpad for your next big leap. Feeling the Pulse of Progress? This is your moment. The Medical Device Manufacturing & R&D Summit is more than an event; it's where the heartbeat of medical innovation grows stronger. We wish opening this invitation was enough to secure your spot. But exclusivity is a key. Only the most forward-thinking, pioneering individuals will walk through these doors. Is that you?...DM me for more info

Medex Medical's General Manager shares thoughts on the future of medical technology and the company's vision. Stay tuned for a glimpse into our strategic initiatives. Shaping Tomorrow's Healthcare: A Visionary Outlook from Medex Medical's As the healthcare landscape continues to evolve, Medex Medical remains at the forefront of innovation, poised to redefine the future of medical technology. Our General Manager, Raymond Huang, provides a glimpse into the strategic initiatives and vision that will shape the trajectory of our company. A Global Vision: Our General Manager envisions Medex Medical as a global leader, transcending borders to bring cutting-edge medical technology to every corner of the world. By fostering international collaborations and partnerships, we aim to create a healthcare ecosystem that knows no bounds. Pioneering Medical Discoveries: At the heart of Medex Medical's vision is a commitment to pioneering medical discoveries. Our General Manager shares insights into the ongoing research and development initiatives that will unveil groundbreaking solutions, pushing the boundaries of what's possible in patient care. Innovation as a Guiding Principle: Innovation is not just a buzzword at Medex Medical; it's a guiding principle. The General Manager sheds light on how we foster a culture of innovation within the company, empowering our teams to think beyond conventions and revolutionize medical technology. Collaboration for Collective Impact: The future of healthcare is collaborative, and Medex Medical is dedicated to forging partnerships that drive collective impact. Learn about our collaborative initiatives with industry leaders, healthcare providers, and research institutions to create a united front in advancing medical technology. Strategic Roadmap Unveiled: Get ready for an exclusive look at Medex Medical's strategic roadmap. Our General Manager provides insights into the planned initiatives, product launches, and technological advancements that will define our journey in the coming years. Stay tuned for a thought-provoking discussion that transcends the present and ventures into the future of healthcare. Medex Medical is not just adapting to change; we are driving change, and our General Manager's vision is the compass guiding us toward a future where medical technology transforms lives globally. #MedTechVisionary #HealthcareInnovation #MedexCEOInsights #FutureOfHealthcare #MedicalTechnologyLeadership

Insights from our CEO Daniel, on the recent FDA’s 2024 Innovation Report. A must-read for medical device manufacturers. TLDR: the future is here, medical device innovation and regulatory flexibility are a priority, and we at BioT are well-positioned to help medical device manufacturers commercialize their devices while staying compliant. These developments are set to enhance the ways medical devices are brought to market and managed, and are aligned perfectly with our innovative solutions. Our commitment to bringing better care to patients wherever they are has never been stronger. P.S. The link to the full report is in the comments. #medtech #FDA #medicaldevices #digitalhealth #BioT

🚀 Excited to share our latest blog post on how Deviceology Ltd. is partnering with Anthropos for success! Discover how our collaboration is driving innovation and excellence in healthcare technology. 💡💼 Read more about our journey and the impact we're making together. 🌟 👉 https://lnkd.in/dsEZy2JE

• 🗣 INTERVIEW - Les Echos - Eric Dessertenne discusses the challenges facing the connected medical devices market • This interview with Eric Dessertenne, CEO of Biocorp, offers a fascinating insight into the challenges and opportunities in the world of connected medical devices. 🎯 In this exclusive interview with Les Echos, Eric Dessertenne discusses the key challenges facing the connected medical devices market in France: long-term adoption by patients and healthcare professionals, reimbursement issues and regulatory constraints. He highlights the crucial need for success stories to attract investors and drive innovation in the field of connected medical devices. 💡 Vision for the future: Eric Dessertenne shares his endorsement of the reimbursement scheme proposed by the Haute Autorité de Santé (HAS) - early assumption of repayment (PECAN), while also discussing the challenges of interpreting real-life data, highlighting the complexities of the sector. 📈 To encourage the development of the sector: He stresses the importance of supporting start-ups, providing tangible evidence of success, and showcasing compelling examples to drive investment, paving the way for a bright future for digital medical devices. Here is the link to the article, which is written in French : https://lnkd.in/eGvD-DF5

Hank Kohl thank you for raising this important discussion on medical device commercialization. You make excellent points about the need to balance time to market with thoughtful market adoption strategies. I agree that while accelerating time to market is crucial, ensuring true market acceptance requires deep understanding of all stakeholder needs, not just end-users. Value analysis committees, key opinion leaders, clinicians, patients - their criteria and priorities must all be considered. An effective commercialization strategy starts long before market launch. It entails designing devices for improved patient outcomes and clinician workflow from the onset. By considering ease-of-use, training requirements, maintenance needs etc. for each stakeholder group early on, greater adoption can be achieved. Furthermore, positioning relative to current competitive landscapes is critical. Benchmarking devices on safety, efficacy and cost versus alternatives can demonstrate the value proposition to stakeholders like VACs. This evidence-based approach to differentiation is key. Lastly, human-centered design principles that deeply engage patient and clinician input are invaluable. Observing real-world environments and workflows ensures products fit seamlessly into existing ecosystems. The most transformative devices solve pressing problems through intuitive and delightful experiences for all involved. Medical technology done right improves lives while also meeting the complex needs of all stakeholders. There are immense opportunities ahead to innovate devices that balance time to market with achieving broad adoption and lasting impact. Revathi Advaithi Todd Kelsey Keith Gausmann Joe Mullings Kenny Wilson Steve Borges Tom Rauch Marcel Hill #medtech #surgicalrobotics #medicaldevices Medtronic Digital Surgery Johnson & Johnson MedTech Intuitive Moon Surgical Distalmotion

𝐅𝐫𝐨𝐦 𝐌𝐞𝐝𝐬𝐤𝐚 𝐭𝐨 𝐌𝐞𝐝𝐢𝐜𝐥𝐮𝐬𝐭𝐞𝐫𝐬: Our Journey 🚀 #CompanyHistory #MedicalCommerce We are excited to share the evolution of our company, from our humble beginnings as Medska to our current status as Mediclusters. This journey has been marked by innovation, growth, and a commitment to revolutionizing the medical trade industry. 𝐊𝐞𝐲 𝐌𝐢𝐥𝐞𝐬𝐭𝐨𝐧𝐞𝐬 𝐟𝐫𝐨𝐦 2007 𝐭𝐨 𝐏𝐫𝐞𝐬𝐞𝐧𝐭: 📅 2007: 𝐓𝐡𝐞 𝐁𝐞𝐠𝐢𝐧𝐧𝐢𝐧𝐠 Our story began in 2007 with the founding of Medska, a company dedicated to providing high-quality medical devices to healthcare professionals. 🚀 2010: 𝐄𝐱𝐩𝐚𝐧𝐝𝐢𝐧𝐠 𝐇𝐨𝐫𝐢𝐳𝐨𝐧𝐬 Recognizing the need for a more integrated approach, we expanded our offerings to include a wider range of medical products and educational resources. 🌍 2015: 𝐆𝐨𝐢𝐧𝐠 𝐆𝐥𝐨𝐛𝐚𝐥 We took a significant step by entering international markets, enabling us to connect with healthcare providers and manufacturers worldwide. 🔗 2018: 𝐒𝐢𝐦𝐩𝐥𝐢𝐟𝐲𝐢𝐧𝐠 𝐭𝐡𝐞 𝐒𝐮𝐩𝐩𝐥𝐲 𝐂𝐡𝐚𝐢𝐧  We introduced direct connections between buyers and manufacturers, eliminating intermediaries to streamline the supply chain and reduce costs. 💡 2020: 𝐄𝐦𝐛𝐫𝐚𝐜𝐢𝐧𝐠 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 With the integration of advanced technologies such as AI and digital health tools, we enhanced our platform to provide more efficient and personalized services. 📚 2022: 𝐁𝐞𝐲𝐨𝐧𝐝 𝐚 𝐌𝐚𝐫𝐤𝐞𝐭𝐩𝐥𝐚𝐜𝐞 We transformed our platform into a comprehensive ecosystem that includes educational resources, industry insights, and robust post-purchase support. 🌟 2024: 𝐑𝐞𝐛𝐫𝐚𝐧𝐝𝐢𝐧𝐠 𝐚𝐬 𝐌𝐞𝐝𝐢𝐜𝐥𝐮𝐬𝐭𝐞𝐫𝐬 To reflect our expanded vision and commitment to excellence, we rebranded as Mediclusters. Our new identity symbolizes the culmination of our efforts to revolutionize medical trade and connect the global healthcare community. We are proud of our journey and the milestones we have achieved. As Mediclusters, we remain dedicated to fostering innovation, improving access to medical advancements, and supporting the healthcare industry at every step. Join us as we continue to lead the way in medical commerce. Follow our page for more updates and insights!

Frost & Sullivan's recent Think Tank explored the theme of Leveraging Downstream Perspectives for Medical Technology New Product Development. This engaging discussion featured industry experts highlighted actionable growth opportunities and essential strategies for effectively commercializing healthcare technology. Check out the Key Takeaways from the session 👉 https://frost.ly/9sn Charlie Whelan | Dave Ribble | Skylar Talley | MedScout | Mark Mescher

Bringing a medical device to the market may be challenging. Join this webinar to hear how to navigate the medical device industry. ⏰ When: March 26, 10-11 🌐 Where: online You will find out how due diligence assists investors with estimating the profitability of financing decisions by evaluating the company’s business operations and risks. Many medical device companies have relatively few instructions on good practices related, for example, to inspections. In this webinar, the speakers will discuss methods and critical topics necessary for determining the market readiness of a medical device company. Learn more and register to the event: https://lnkd.in/duvYcWTv

A few days ago the FDA released the yearly Innovation Report. The report highlights several key initiatives aimed at advancing medical device innovation and regulatory flexibility. This is a big deal, directly impacting how at BioT Medical we can help medical device manufacturers, in several ways: 1- Enhanced Regulatory Pathways The FDA streamlined its premarket review processes and introduced programs like the Breakthrough Devices Program and the Safer Technologies Program (STeP). These initiatives are designed to facilitate faster access to the market for life-saving and innovative medical devices by expediting their regulatory review. As a leading cloud infrastructure that supports medical device manufacturers, this could mean quicker pathways to commercialization for devices developed using our platform. 2- Digital Health and AI Integration The FDA made significant advances in regulatory frameworks to better accommodate digital health innovations, including AI/ML-enabled devices. As a result, approximately 700 AI/ML devices have been authorized. This indicates a growing acceptance and integration of high-tech solutions in healthcare. Our cloud-native solutions, which enable to incorporate AI algorithms and data analytics, are well-positioned to help medical device manufacturers leverage these regulatory adaptations. 3- Home as a Health Care Hub The FDA is focusing on expanding the concept of home health care, which aligns with our capabilities to support remote monitoring and management of health conditions through cloud-connected medical devices. This amplifies the value we can bring, as more medical devices are used in home settings. 4- Use of Real-World Evidence (RWE) The FDA is increasingly accepting RWE in regulatory decisions, which complements our ability to collect and analyze real-world data from devices. This could facilitate more streamlined regulatory submissions and product improvements based on actual usage data. It’s great to see such innovative initiatives from a government institution. Our industry is making great strides, and I’m proud to see BioT at the forefront, empowering medical device manufacturers to create a future that is more connected and patient-focused. P.S. The link to the full report is in the comments. ----- Unsure how to navigate the FDA changes? We can help. Book a free 1:1 session with a BioT expert here: https://lnkd.in/duUcyhW4 #healthcare #FDA #medicaldevices #medtech